quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:36:00·646d
INSIDERFiling
Monterey Capital Acquisition Corporation logo

Officer Subramanya Girish was granted 431,775 shares (SEC Form 4)

MCAC· Monterey Capital Acquisition Corporation
Finance
Original source

Companies

  • MCAC
    Monterey Capital Acquisition Corporation
    Finance

Related

  • 13D/G643d
    SEC Form SC 13D filed by Monterey Capital Acquisition Corporation
  • 13D/G644d
    SEC Form SC 13D filed by Monterey Capital Acquisition Corporation
  • SEC644d
    Monterey Capital Acquisition Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Leadership Update, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics, Change in Shell Com
  • INSIDER646d
    Director Cuocolo Kathleen C converted options into 25,000 shares, disposed of 25,000 shares and acquired 25,000 shares (SEC Form 4)
  • INSIDER646d
    Director Markscheid Stephen converted options into 25,000 shares, disposed of 25,000 shares and acquired 25,000 shares (SEC Form 4)
  • INSIDER646d
    Officer Padmakumar Bala converted options into 1,625,000 shares, disposed of 1,625,000 shares and acquired 1,625,000 shares (SEC Form 4)
  • INSIDER646d
    Officer Panigrahi Bhaskar was granted 3,968,145 shares (SEC Form 4)
  • INSIDER646d
    SEC Form 4 filed by Officer Choudhury Mahesh
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022